Business description
AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.
Management board & Supervisory board
CEO |
Pascal Soriot |
Management board |
Aradhana Sarin, David Fredrickson, Iskra Reic, Jeff Pott, Katarina Ageborg, Leon Wang, Marc Dunoyer, Menelas Pangalos, Pam Cheng, Ruud Dobber, Susan Galbraith |
Supervisory board |
Leif Johannson, Andreas Rummelt, Aradhana Sarin, Deborah DiSanzo, Diana Layfield, Euan Ashley, Marcus Wallenberg, Michel Demaré, Nazneen Rahman, Pascal Soriot, Philip Broadley, Sheri McCoy, Tony Mok |
Company data
Name: |
AstraZeneca plc |
Address: |
2 Kingdom Street,UK-London W2 6BD |
Phone: |
+44-20-7604-8000 |
Fax: |
+44-20-7604-8151 |
E-mail: |
-
|
Internet: |
www.astrazeneca.com |
Industry: |
Healthcare |
Sector: |
Pharmaceutical Industry |
Sub sector: |
Pharmaceuticals |
End of financial year: |
12/31 |
Free Float: |
77.64% |
IPO date: |
- |
Investor relations
Name: |
Chris Sheldon |
IR phone: |
+44-203-749-5712 |
IR Fax: |
- |
IR e-mail: |
IR@astrazeneca.com
|